Immucell (ICCC) Income from Non-Controlling Interests (2020 - 2023)

Immucell (ICCC) has 4 years of Income from Non-Controlling Interests data on file, last reported at -$1.4 million in Q2 2023.

• Quarterly Income from Non-Controlling Interests fell 101.67% year-over-year to -$1.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$6.0 million (down 11890.88% YoY) and the FY2022 annual result came in at -$2.5 million, down 3085.26% from the prior year.
• Income from Non-Controlling Interests rose to -$1.4 million in Q2 2023, from -$2.3 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of $513287.0 in Q1 2022 to a low of -$2.3 million in Q1 2023.
• A 4-year average of -$551285.8 and a median of -$441303.0 in 2021 frame the typical range for Income from Non-Controlling Interests.
• The widest YoY moves for Income from Non-Controlling Interests: up 216.31% in 2022, down 2349.8% in 2022.
• Tracing ICCC's Income from Non-Controlling Interests over 4 years: stood at $188830.0 in 2020, then plunged by 60.74% to $74134.0 in 2021, then slumped by 2349.8% to -$1.7 million in 2022, then gained by 17.28% to -$1.4 million in 2023.
• The last three Income from Non-Controlling Interests figures came in at -$1.4 million (Q2 2023), -$2.3 million (Q1 2023), and -$1.7 million (Q4 2022), per Business Quant data.